A randomized phase III study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) Meeting Abstract
| Authors: | Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Staddon, A. P.; Milhem, M. M.; Elias, A. D.; Ganjoo, K. N.; Tawbi, H. A. H.; Van Tine, B. A.; Spira, A. I.; Dean, A. P.; Khokhar, N. Z.; Park, Y. C.; Knoblauch, R. E.; Parekh, T. V.; Maki, R. G.; Patel, S. |
| Abstract Title: | A randomized phase III study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036900137 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.10503 |
| Notes: | Meeting Abstract: 10503 -- Source: Wos |
